All Stories

  1. White matter hyperintensities in dementia with lewy bodies and posterior cortical atrophy
  2. Aβ 42/40 and p-tau 181 as disease biomarkers in atypical Alzheimer's disease
  3. Clinical Utility of Tectal Plate Measurements on Magnetic Resonance Imaging in Progressive Supranuclear Palsy
  4. Altered structural and functional connectivity in Posterior Cortical Atrophy and Dementia with Lewy bodies
  5. Longitudinal default mode sub-networks in the language and visual variants of Alzheimer’s disease
  6. Speech-language within and between network disruptions in primary progressive aphasia variants
  7. Longitudinal rates of atrophy and tau accumulation differ between the visual and language variants of atypical Alzheimer's disease
  8. Diffusivity Changes in Posterior Cortical Atrophy and Logopenic Progressive Aphasia: A Longitudinal Diffusion Tensor Imaging Study
  9. Acoustic analysis and neuroimaging correlates of diadochokinetic rates in mild-moderate primary progressive apraxia of speech
  10. APOE ε4 influences within and between network functional connectivity in posterior cortical atrophy and logopenic progressive aphasia
  11. Clinicopathological associations of hemispheric dominance in primary progressive apraxia of speech
  12. Altered within- and between-network functional connectivity in atypical Alzheimer’s disease
  13. Atypical Alzheimer’s disease phenotypes with normal or borderline PET biomarker profiles
  14. APOE ε4 influences medial temporal atrophy and tau deposition in atypical Alzheimer’s disease
  15. Unique spatiotemporal fMRI dynamics in the awake mouse brain
  16. Distinct brain iron profiles associated with logopenic progressive aphasia and posterior cortical atrophy
  17. EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer’s Disease
  18. Inhibition of Al(III)-Induced Aβ42 Fibrillation and Reduction of Neurotoxicity by Epigallocatechin-3-Gallate Nanoparticles
  19. Fabrication of PLA-PEG Nanoparticles as Delivery Systems for Improved Stability and Controlled Release of Catechin
  20. Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)